Tune in for a “dynamic” webcast addressing formulation and stability of protein therapeutics with high-throughput dynamic light scattering. Live: Tuesday, Aug. 20, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until Aug. 20, 2020 Register free

Wyatt Technology

Articles by Wyatt Technology

Understanding Antibody and Viral Glycoprotein Interactions

SEC-MALS Method for Characterizing mRNA

AAV CQA Analysis by SEC-MALS

AAV Quantitation and Stability Analysis

Identification of Insulin Oligomeric States

The Versatility of High Throughput Dynamic Light Scattering in Protein Characterization and Formulation Development

Trending on BioPharm International

FDA Rare Disease Framework Initiative: What It Means for Drug and Biologic Development

FDA Accepts BLA for Formycon and Zydus’ FYB206, the First Publicly Announced Keytruda Biosimilar Under Review

Gilead Taps Vir Biotechnology's PRO-XTEN Tech for Solid Tumors

FDA’s ARC Program Highlights Opportunities and Limits of Bayesian Methods in Rare Disease Trials

BioNTech's BNT113 Misses PFS Goal in Head and Neck Cancer Trial